NewsCoronavirus

Actions

Lilly seeks emergency use of its antibody drug for COVID-19

Virus Outbreak-Antibody Drug
Posted at 7:17 PM, Oct 07, 2020
and last updated 2020-10-07 19:17:42-04

INDIANAPOLIS — A drug company says it has asked the U.S. government to allow emergency use of an experimental antibody therapy based on early results from a study that suggested the drug reduced symptoms, the amount of virus, hospitalizations and ER visits for patients with mild or moderate COVID-19.

Eli Lilly and Company announced the partial results Wednesday in a news release; they have not yet been published or reviewed by independent scientists.

Its drug is similar to one that President Donald Trump received on Friday from a different company.

These medicines supply concentrated versions of specific antibodies to help the immune system clear the coronavirus that causes COVID-19.